PHR
Phreesia Inc
NYSE · Health Care
$12.20
-0.39 (-3.10%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 439.47M | 350.63M | 275.50M | 281.83M | 261.10M |
| Net Income | -61,269,683 | -43,994,506 | 31.02M | 28.13M | 27.33M |
| EPS | — | — | — | — | — |
| Profit Margin | -13.9% | -13.2% | 11.3% | 10.0% | 10.5% |
| Rev Growth | +25.3% | +25.3% | +19.3% | +22.7% | +1.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 21.18M | 21.18M | 267.58M | 344.83M | 272.53M |
| Total Equity | 346.57M | 346.57M | 486.40M | 470.50M | 469.83M |
| D/E Ratio | 0.06 | 0.06 | 0.55 | 0.73 | 0.58 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -29,576,804 | -22,417,395 | 31.68M | 35.18M | 32.43M |
| Free Cash Flow | — | — | 34.92M | 39.14M | 27.19M |